Wakefield Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$707K Sell
2,008
-17
-0.8% -$6.06K 0.19% 144
2025
Q4
$663K Buy
2,025
+66
+3% +$20.9K 0.18% 148
2025
Q3
$553K Sell
1,959
-15
-0.8% -$4.35K 0.15% 150
2025
Q2
$551K Buy
+1,974
New +$559K 0.15% 155
2024
Q4
Sell
-1,228
Closed -$396K 147
2024
Q3
$396K Buy
1,228
+20
+2% +$6.54K 0.13% 136
2024
Q2
$377K Sell
1,208
-390
-24% -$115K 0.13% 136
2024
Q1
$454K Sell
1,598
-27
-2% -$7.9K 0.16% 134
2023
Q4
$468K Buy
1,625
+533
+49% +$145K 0.17% 131
2023
Q3
$293K Sell
1,092
-569
-34% -$142K 0.13% 141
2023
Q2
$369K Buy
+1,661
New +$385K 0.15% 139
2020
Q1
Sell
-1,158
Closed -$279K 156
2019
Q4
$279K Buy
1,158
+60
+5% +$13.2K 0.12% 140
2019
Q3
$212K Buy
+1,098
New +$211K 0.09% 145

Other funds holding AMGN

Wakefield Asset Management's AMGN Position: Q1 2026 in Review

Wakefield Asset Management reduced its Amgen (AMGN) stake by 0.84% in Q1 2026, selling an estimated $6.06K and leaving 2,008 shares worth $707K. The position accounts for 0.19% of the portfolio, ranked #144.

Wakefield Asset Management first reported a position in AMGN in Q3 2019 and has held it in 12 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Wakefield Asset Management held 2,008 shares of Amgen worth $707K as of Q1 2026.
  • Wakefield Asset Management sold 17 Amgen shares in Q1 2026, an estimated $6.06K.
  • Amgen made up 0.19% of Wakefield Asset Management's portfolio in Q1 2026, its #144 holding.
  • Wakefield Asset Management first reported a position in Amgen in Q3 2019 and has held it in 12 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Wakefield Asset Management's 13F filing for Q1 2026, filed 12 May 2026.